BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• 

  Drug Development

  GlaxoSmithKline’s Experimental Ebola Vaccine Protects Monkeys For 10 Months

  September 8, 2014

   · 

  2 min read
• Drug Development

  Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Demonstrates Potent In Vitro Activity Of New Antibiotic Class Against Gram Negative ESKAPE Pathogens

  September 8, 2014

   · 

  5 min read
• Business

  Ophthotech Corporation Banks $50 Million Milestone From Novartis AG For Fovista® Pact

  September 8, 2014

   · 

  6 min read
• BioMidwest

  Cook Medical’s CloverSnare Recall Gets FDA’s Highest-Risk Label

  September 8, 2014

   · 

  1 min read
• Business

  Bruno Lucidi New CEO In Karolinska Development AB Oncology Companies

  September 8, 2014

   · 

  3 min read
• Policy

  Court Orders Johnson & Johnson To Pay $3.27 Million Over Mesh Implant

  September 8, 2014

   · 

  1 min read
• Pharm Country

  Salk Institute for Biological Studies Release: New Study Shows Simple Conversion Of Skin Cells Into White Blood-Like Cells

  September 8, 2014

   · 

  2 min read
• Business

  CryoPort, Inc. Appoints VP Of Strategic Business Development And Accelerates Expansion Of Direct Sales Force

  September 8, 2014

   · 

  4 min read
• Pharm Country

  Edge Therapeutics Grabs $10 Million Venture Loan

  September 8, 2014

   · 

  5 min read
• Drug Development

  Mast Therapeutics Reports Positive Results From Phase 2 Pulmonary Arterial Hypertension Study

  September 8, 2014

   · 

  8 min read